Clinical Trials Logo

Glioblastoma Surgery clinical trials

View clinical trials related to Glioblastoma Surgery.

Filter by:
  • None
  • Page 1

NCT ID: NCT04782609 Terminated - Clinical trials for Recurrent Glioblastoma Multiforme (GBM)

Study of Icapamespib (PU-AD) in Patients With Recurrent Malignant Glioma

Glio
Start date: December 27, 2021
Phase: Phase 1
Study type: Interventional

This is a 2-part multicenter Phase 1b study designed to test icapamespib in patients with recurrent brain lesions. Part 1 of the trial will be a standard 3 by 3 dose escalation design where different doses are examined. Part 2 will be a dose expansion cohort to further evaluate the recommended Phase 2 dose (RP2D). The RP2D is defined as the dose level recommended for further clinical study, or the highest dose tested.